Bausch Health Cos., Inc. (BHC.TO)
9.23
+0.41
(+4.65%)
CAD |
TSX |
Aug 24, 16:00
Bausch Health Cos. Profit Margin (Quarterly) : 9.12% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.12% |
| March 31, 2026 | -56.70% |
| December 31, 2025 | -3.68% |
| September 30, 2025 | 6.75% |
| June 30, 2025 | 5.06% |
| March 31, 2025 | -3.81% |
| December 31, 2024 | 3.83% |
| September 30, 2024 | -3.67% |
| June 30, 2024 | -0.04% |
| March 31, 2024 | -3.58% |
| December 31, 2023 | -1.95% |
| September 30, 2023 | -17.07% |
| June 30, 2023 | 1.25% |
| March 31, 2023 | -10.75% |
| December 31, 2022 | -18.70% |
| September 30, 2022 | 19.70% |
| June 30, 2022 | -7.07% |
| March 31, 2022 | -3.44% |
| December 31, 2021 | 3.28% |
| September 30, 2021 | 9.05% |
| June 30, 2021 | -28.24% |
| March 31, 2021 | -29.95% |
| December 31, 2020 | -6.87% |
| September 30, 2020 | 3.27% |
| June 30, 2020 | -19.53% |
| Date | Value |
|---|---|
| March 31, 2020 | -7.55% |
| December 31, 2019 | -68.21% |
| September 30, 2019 | -2.17% |
| June 30, 2019 | -7.90% |
| March 31, 2019 | -2.38% |
| December 31, 2018 | -16.12% |
| September 30, 2018 | -16.43% |
| June 30, 2018 | -40.98% |
| March 31, 2018 | -129.3% |
| December 31, 2017 | 23.67% |
| September 30, 2017 | 58.58% |
| June 30, 2017 | -1.66% |
| March 31, 2017 | 29.82% |
| December 31, 2016 | -21.31% |
| September 30, 2016 | -49.17% |
| June 30, 2016 | -12.56% |
| March 31, 2016 | -15.72% |
| December 31, 2015 | -14.01% |
| September 30, 2015 | 1.86% |
| June 30, 2015 | -1.89% |
| March 31, 2015 | 4.54% |
| December 31, 2014 | 22.89% |
| September 30, 2014 | 13.44% |
| June 30, 2014 | 5.98% |
| March 31, 2014 | -1.08% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| HLS Therapeutics, Inc. | -6.95% |
| Cipher Pharmaceuticals, Inc. | 33.26% |
| BioSyent, Inc. | 14.34% |
| Revive Therapeutics Ltd. | -- |
| Knight Therapeutics, Inc. | -2.33% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -4.16% |
| Return on Invested Capital | -5.17% |
| Gross Profit Margin (Quarterly) | 65.04% |
| Operating Margin (Quarterly) | 27.17% |
| Return on Net Operating Assets | -5.07% |